Insmed education effort targets Congress, public
RICHMOND, VA: Insmed, a developer of follow-on biologics (FOBs) and biopharmaceuticals, has launched a broad education campaign in its hopes to raise awareness of the importance of establishing a regulatory pathway in the US for FOBs.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.